Value-Based Medicine News
Experts Argue COVID-19 Provides Opportunity to Implement Value-Based Care Practices
August 13th 2020In a webinar, experts outlined challenges providers face amid the coronavirus disease 2019 (COVID-19) pandemic and the benefits of increased access to high-value care during the outbreak and beyond.
Read More
Supplemental Process Can Aid in Assessing Value of Rare Disease Treatments
July 25th 2020A study looking at the ways in which different countries handle appraisal and reimbursement processes for rare disease treatments (RDTs) revealed that implementing supplemental processes can aid in patient and physician decision making.
Read More
CMS Issues Rules to Promote Value-Based Contracting, Pay for High-Cost Therapies in Medicaid
June 18th 2020Administrator Seema Verma said the proposal would create opportunities "for drug manufacturers to have skin in the game through payment arrangements that challenge them to put their money where their mouth is."
Read More
Linking Opportunity Costs and Value Assessments for State and Commercial Payers
May 20th 2020When deciding which treatments to cover, states and commercial payers must wrestle with opportunity costs as new therapeutics come to market. A panel at Virtual ISPOR 2020 discussed some of the factors that go into those decisions.
Read More
Virtual ISPOR Panel to Examine Next Steps in Value Assessment
May 18th 2020Two of the panelists appearing during the Virtual ISPOR 2020 meeting preview what's needed in improving value assessment: Lou Garrison, PhD, of the University of Washington, and Leah Howard, JD, of the National Psoriasis Foundation.
Read More
NAACOS: ACOs Saved Medicare $3.5 Billion From 2013 to 2017
December 4th 2019Accountable care organizations (ACOs) have saved Medicare a total of $3.53 billion from 2013 to 2017, or $755 million after shared savings were paid out, according to a new report from the National Association of ACOs (NAACOS).
Read More
Value Considerations Should Begin Very Early in the New Drug Development Life Cycle
October 31st 2019Value needs to be considered early in the development life cycle of a therapy and should be continued throughout, even into the postlaunch space using real-world studies, according to a presentation on value-based services and their life cycles at the AMCP Nexus 2019 meeting.
Read More
HHS Releases Proposal to Reform Stark Law, Antikickback Rules
October 9th 2019In a long-awaited move, HHS announced Tuesday plans to reform federal antikickback statutes and overhaul the so-called Stark Law, which was originally intended as a safeguard against financial incentives that would inappropriately influence physicians’ clinical decisions, in an effort to speed the transition to value-based care.
Read More